The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.
Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
9hon MSN
LuxExperience to Sell The Outnet
The sale is a strategic step in line with LuxExperience's transformation plan unveiled last May to simplify its operating ...
Passport reports AI is transforming e-commerce with faster conversions, but also highlights operational pressures on ...
Tradeweb completes fully electronic RFM swaptions trade, IBM cashes in on digital asset mania, and more frights and delights ...
Q3 2025 Earnings Call Transcript October 30, 2025 Amazon.com, Inc. beats earnings expectations. Reported EPS is $1.95, ...
AI Computing Power investment is a new model that is quietly changing the game in 2025 when the AI-powered world is growing exponentially. With the worldwide AI investment estimated to reach $1.5 ...
Humanoid robots capture the public imagination, and investors are backing them. That means a lot of reports will be incoming, ...
AM Best has affirmed the Long-Term Issue Credit Ratings (Long-Term IRs) of "aaa" (Exceptional) on the $74,646,000 Class A-1 8 ...
Celosphere case studies will show how companies turn disruption into advantage. Smurfit Westrock uses PI to optimize inventory and reduce costs amid tariff uncertainty, while ASOS leverages PI to ...
Colnago has today launched a brand new track bike named the T1Rs. Following on from the hyper aero Y1RS road machine, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results